BUZZ-Street View: 3M's business initiatives might extend its 'honeymoon' phase

U.S. industrial conglomerate 3M Co MMM.N forecast profit growth for 2025 and beat fourth-quarter estimates as benefited from efforts to revive sales and reduce costs

Median PT of nineteen brokerages covering the stock is $152 - LSEG data

PFAS MAY BE AN OVERHANG

J.P. Morgan ("overweight," PT: $165) sees potential for business productivity gains and modest revenue growth, especially in the near-term

"It’s too early to call end to the Honeymoon phase, which we would argue has yet to start, and see lasting likely through 2025" - JPM

BofA Global Research ("buy," PO: $175) believes that co will offer clarity into its long-term productivity initiatives, which brokerage sees as crucial for driving earnings growth over the next several years

RBC ("underperform," PT: $96) says co faces unresolved liabilities related to per- and polyfluoroalkyl substances (PFAS), which could amount to an overhang worth billions of dollars

Barclays ("neutral," PT: $165) sees co's 2025 guidance as encouraging, highlighting strong operating margin growth despite no clear improvement in organic sales momentum

(Reporting by Akriti Shah in Bengaluru)

((akriti.shah@thomsonreuters.com))